ROIV
Companies
NASDAQ
Roivant Sciences Ltd
Health Care
$11.44
-$0.39 (-3.30%)
Price Chart
Overview
About ROIV
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
Market Cap
$7.7B
Volume
52.3M
Avg. Volume
71.4M
P/E Ratio
-9.008403
Dividend Yield
0.00%
Employees
608.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Latest News for ROIV
Roivant Sciences Offloads Psoriasis Medicine Maker To Organon For Up To $1.2B
September 18, 2024
A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free
October 24, 2023
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates
May 29, 2025
Risk & Correlation Analysis
Market Correlation
0.37
Low Correlation
Volatility
Medium (0.34)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ROIV shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$7.7B
Volume52.3M
P/E Ratio-9.01
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025